Abstract
In clinical studies, the illness-death model is often used to describe disease progression. A subject starts disease-free, may develop the disease and then die, or die directly. In clinical practice, disease can only be diagnosed at pre-specified follow-up visits, so the exact time of disease onset is often unknown, resulting in interval-censored data. This study examines the impact of ignoring this interval-censored nature of disease data on the discrimination performance of illness-death models, focusing on the time-specific area under the receiver operating characteristic curve in both incident/dynamic and cumulative/dynamic definitions. A simulation study with data simulated from Weibull transition hazards and disease state censored at regular intervals is conducted. Estimates are derived using different methods: the Cox model with a time-dependent binary disease marker, which ignores interval-censoring, and the illness-death model for interval-censored data estimated with three implementations—the piecewise-constant model from the msm package, the Weibull and M-spline models from the SmoothHazard package. These methods are also applied to a dataset of 2232 patients with high-grade soft tissue sarcoma, where the interval-censored disease state is the post-operative development of distant metastases. The results suggest that, in the presence of interval-censored disease times, it is important to account for interval-censoring not only when estimating the parameters of the model but also when evaluating the discrimination performance of the disease.
| Original language | English |
|---|---|
| Pages (from-to) | 469-487 |
| Number of pages | 19 |
| Journal | Statistical Methods in Medical Research |
| Volume | 35 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 2026 |
Keywords
- AUC
- discrimination
- illness-death model
- interval-censoring
- time-dependent disease marker
Fingerprint
Dive into the research topics of 'Discrimination performance in illness-death models with interval-censored disease data'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver